A retrospective clinical, laboratory and outcome analysis in 43 cases of acute aseptic meningitis.
Forty-three consecutive cases of acute aseptic meningitis (AAM) presenting within a 24-months period were retrospectively analysed with respect to clinical symptomatology, cerebrospinal fluid (CSF) findings, clinical course, treatment and outcome. Nineteen of the 43 AAM cases (44%) were caused by enterovirus, one by HIV (2%), two by Varicella zoster virus (5%), three due to herpes simplex virus I (7%), two due to herpes simplex virus II (5%), one due to Central European encephalitis virus (2%), and in 15 patients (35%) the aetiology of AAM remained unknown. Headache (100%) and fever (93%) were the presenting symptoms in the majority of cases. Signs of preceding infection were predominantly gastrointestinal in the enterovirus subgroup, but were inconsistently observed in the other subgroups. CSF findings at the first lumbar tap on admission generally revealed lymphomonocytic pleocytosis of less than 500 cells per micro l, mild to moderately elevated protein and normal lactate and glucose levels. Initial therapy consisted of an empirical antiviral and antibiotic regimen until a serological diagnosis was available. Acyclovir, effective only in herpes family viruses, was initially administered to all AAM cases. Effective therapy for other viral pathogens are not broadly available and treating AAM of unknown aetiology imposes a particular problem. The average hospitalization time ranged from 16 to 31 days. Patients were either discharged home (72%) or transferred to a rehabilitation centre (28%). The outcome was good (40%) to fair (51%) in the majority of cases.
Nowak
D A
DA
Departments of Neurology and Clinical Neurophysiology and Medical Microbiology and Immunology, Academic Hospital Munich-Bogenhausen, Technical University of Munich, Munich, Germany. DrDennis.Nowak@gmx.de
Boehmer
R
R
Fuchs
H-H
HH
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004562:Electrocardiography / Q000295:instrumentation; D004569:Electroencephalography / Q000295:instrumentation; D004675:Encephalitis, Tick-Borne / Q000821:virology; D004770:Enterovirus / Q000302:isolation & purification; D005260:Female; D006678:HIV / Q000302:isolation & purification; D018259:Herpesvirus 1, Human / Q000302:isolation & purification; D018258:Herpesvirus 2, Human / Q000302:isolation & purification; D014645:Herpesvirus 3, Human / Q000302:isolation & purification; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008582:Meningitis, Aseptic / Q000134:cerebrospinal fluid / Q000503:physiopathology* / Q000628:therapy / Q000821:virology*; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D012189:Retrospective Studies; D012621:Seasons; D012698:Serologic Tests / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000295:instrumentation; D016896:Treatment Outcome